Cover Image

Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma

Recurrence of primary central nervous system lymphoma (PCNSL) after high-dose chemotherapy with autologous stem cell transplantation (ASCT) usually has a poor overall prognosis with limited treatment options. Data on repeated ASCT are sparse. Checkpoint inhibitor maintenance therapy has also not bee...

Full description

Saved in:
Bibliographic Details
Main Authors: Terziev, Denis (Author) , Stenzinger, Albrecht (Author) , Stögbauer, Fabian (Author) , Glimm, Hanno (Author) , Fröhling, Stefan (Author) , Jordan, Karin (Author)
Format: Article (Journal)
Language:English
Published: 06 April 2018
In: European journal of haematology
Year: 2018, Volume: 101, Issue: 1, Pages: 115-118
ISSN:1600-0609
DOI:10.1111/ejh.13072
Online Access:Verlag, Volltext: https://doi.org/10.1111/ejh.13072
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13072
Get full text
Author Notes:Denis Terziev, Barbara Hutter, Barbara Klink, Albrecht Stenzinger, Fabian Stögbauer, Hanno Glimm, Stefan Fröhling, Claudia Wickenhauser, Karin Jordan, Hans-Jürgen Hurtz, Lutz P. Müller, Jörn Rüssel, Thomas Weber
Description
Summary:Recurrence of primary central nervous system lymphoma (PCNSL) after high-dose chemotherapy with autologous stem cell transplantation (ASCT) usually has a poor overall prognosis with limited treatment options. Data on repeated ASCT are sparse. Checkpoint inhibitor maintenance therapy has also not been reported in PCNSL. Here, we report the first documented case of a successful third ASCT in second relapse of PCNSL. Whole-exome sequencing identified a hypermutated tumor genotype. Additionally, immunohistochemistry on pretreatment tumor tissue revealed infiltrates of PD-1+ cytolytic T cells. These alterations provided a rationale for subsequent nivolumab maintenance treatment. Therapy led to a long-term, ongoing complete remission. In eligible patients with recurrent MTX-sensitive PCNSL, multiple long-term remissions can be induced by repetition of high-dose MTX-based chemotherapy followed by autologous retransplantation. Subsequent immune checkpoint inhibitor maintenance therapy might be able to prolong or maintain remission.
Item Description:Gesehen am 14.05.2019
Physical Description:Online Resource
ISSN:1600-0609
DOI:10.1111/ejh.13072

Similar Items